Diabetic ketoacidosis inducing myocardial infarction secondary to treatment with dapagliflozin: a case report

Sodium‐glucose cotransporter 2 (SGLT2) inhibitors are able to provoke diabetic ketoacidosis (DKA) with absence or low levels of ketone bodies in urine and slightly elevated blood glucose levels, which could delay the diagnosis; however, the presence of high urine output, due to the excretion of gluc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Case Rep
Autori principali: Gil‐Perdomo, José M., Fariña González, Tomás F., Jordán‐Arias, Benjamín, Domingo‐Marín, Sara, González Armengol, Juan J., Martínez‐Sagasti, Fernando
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Case Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458028/
https://ncbi.nlm.nih.gov/pubmed/28588816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.858
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi